» Articles » PMID: 37062767

Initiating and Imaging Cavitation from Infused Echo Contrast Agents Through the EkoSonic Catheter

Overview
Journal Sci Rep
Specialty Science
Date 2023 Apr 16
PMID 37062767
Authors
Affiliations
Soon will be listed here.
Abstract

Ultrasound-enhanced delivery of therapeutic-loaded echogenic liposomes is under development for vascular applications using the EkoSonic Endovascular System. In this study, fibrin-targeted echogenic liposomes loaded with an anti-inflammatory agent were characterized before and after infusion through an EkoSonic catheter. Cavitation activity was nucleated by Definity or fibrin-targeted, drug-loaded echogenic liposomes infused and insonified with EkoSonic catheters. Passive cavitation imaging was used to quantify and map bubble activity in a flow phantom mimicking porcine arterial flow. Cavitation was sustained during 3-min infusions of Definity or echogenic liposomes along the distal 6 cm treatment zone of the catheter. Though the EkoSonic catheter was not designed specifically for cavitation nucleation, infusion of drug-loaded echogenic liposomes can be employed to trigger and sustain bubble activity for enhanced intravascular drug delivery.

Citing Articles

Overview of Therapeutic Ultrasound Applications and Safety Considerations: 2024 Update.

Bader K, Padilla F, Haworth K, Ellens N, Dalecki D, Miller D J Ultrasound Med. 2024; 44(3):381-433.

PMID: 39526313 PMC: 11796337. DOI: 10.1002/jum.16611.


Overview of Venous Thromboembolism and Emerging Therapeutic Technologies Based on Nanocarriers-Mediated Drug Delivery Systems.

Salavati M, Arabshomali A, Nouranian S, Shariat-Madar Z Molecules. 2024; 29(20).

PMID: 39459251 PMC: 11510185. DOI: 10.3390/molecules29204883.


Therapeutic ultrasound transducer technology and monitoring techniques: a review with clinical examples.

Lafond M, Payne A, Lafon C Int J Hyperthermia. 2024; 41(1):2389288.

PMID: 39134055 PMC: 11375802. DOI: 10.1080/02656736.2024.2389288.


Storage Stability of Atheroglitatide, an Echogenic Liposomal Formulation of Pioglitazone Targeted to Advanced Atheroma with a Fibrin-Binding Peptide.

Klegerman M, Peng T, Huang S, Frierson B, Moody M, Kim H Pharmaceutics. 2023; 15(9).

PMID: 37765257 PMC: 10536356. DOI: 10.3390/pharmaceutics15092288.


Quantifying the Effect of Acoustic Parameters on Temporal and Spatial Cavitation Activity: Gauging Cavitation Dose.

Escudero D, Haworth K, Genstler C, Holland C Ultrasound Med Biol. 2023; 49(11):2388-2397.

PMID: 37648590 PMC: 10581030. DOI: 10.1016/j.ultrasmedbio.2023.08.002.

References
1.
Huang S, Kee P, Kim H, Moody M, Chrzanowski S, MacDonald R . Nitric oxide-loaded echogenic liposomes for nitric oxide delivery and inhibition of intimal hyperplasia. J Am Coll Cardiol. 2009; 54(7):652-9. PMC: 3108325. DOI: 10.1016/j.jacc.2009.04.039. View

2.
Diez-Silva M, Dao M, Han J, Lim C, Suresh S . Shape and Biomechanical Characteristics of Human Red Blood Cells in Health and Disease. MRS Bull. 2010; 35(5):382-388. PMC: 2998922. DOI: 10.1557/mrs2010.571. View

3.
Kwan J, Myers R, Coviello C, Graham S, Shah A, Eleanor Stride . Ultrasound-Propelled Nanocups for Drug Delivery. Small. 2015; 11(39):5305-14. PMC: 4660885. DOI: 10.1002/smll.201501322. View

4.
Bhatnagar S, Schiffter H, Coussios C . Exploitation of acoustic cavitation-induced microstreaming to enhance molecular transport. J Pharm Sci. 2014; 103(6):1903-12. DOI: 10.1002/jps.23971. View

5.
Arvanitis C, Livingstone M, Vykhodtseva N, McDannold N . Controlled ultrasound-induced blood-brain barrier disruption using passive acoustic emissions monitoring. PLoS One. 2012; 7(9):e45783. PMC: 3454363. DOI: 10.1371/journal.pone.0045783. View